UT MD Anderson Cancer

Houston, Texas 77030

We've found

1 trials

at this facility

Vorinostat in Combination With Azacitidine in Patients With Newly-Diagnosed Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS)

Status: Enrolling, Phase II
Updated: 12/11/2013

from

Houston, TX

Use our guide to learn which trials are right for you!